15 November 2022
The Department for Business, Energy & Industrial Strategy (BEIS) has announced the intention to introduce legislation to continue recognition of the CE marking and reversed epsilon marking until 31 December 2024 for most goods being placed on the market or put into service in Great Britain. However, the announcement does not apply to medical devices as these as covered separately by the measures recently announced by the MHRA.
The BEIS announcement also states that legislation will be introduced to give effect to the measures previously announced in June 2022 with amended timescales, in line with the extension. These measures intend to:
- Reduce labelling costs by continuing to allow businesses to affix the UKCA marking, and to include importer information for products from EEA countries (and in some cases, Switzerland) on an accompanying document or a label until 31 December 2027.
- Reduce re-testing costs for UKCA certification by allowing conformity assessment activities for CE marking undertaken by 31 December 2024 to be used by manufacturers as the basis for UKCA marking, until the expiry of the certificate or until 31 December 2027, whichever is sooner.
While the BEIS announcement does not currently impact the recent announcement by the MHRA to extend the current standstill arrangements to July 2024, as spare parts are covered by the BEIS announcement, this may impact some products supplied by your company.
The measures contained in the BEIS announcement, as with the MHRA’s recent announcement for medical devices, are subject to Parliamentary approval.